Hey terry,
do you know how many times they did the 14 day cycles.
This stuff its not cheap.
Matt, bear with me, bro, as I'm trying to find info on studies that are 8 years old; however, here's what I've found:
Phase I Trials: these were completed in 2004. I seem to be finding conflicting stories on dosing protocols. One source says 14 on/off, another says 5 on, etc. Unfortunately, I can't define for certain what protocol was used in this trial. I also can't find a published result for this study, although it did progress to Phase Two. Certainly, there must have been something of merit to warrant further testing in a larger control group (that would've meant spending more $$$ on the project).
Phase IIa Trials: I can't pinpoint a date of completion of this study, but my research indicates in was completed during 2006. The protocol used was once daily/14 days on, a one month drug-free period, and a second cycle of 14 days on. The observation period was 24 weeks from the first treatment. The following is a direct quote from the published results:
"Results show that NEOSH101 was safe and well tolerated. A statistically significant increase in total hair count (4.8%, p=0.04), and cumulative hair thickness (3.7%, p=0.02) were observed, with peak effects occurring eight weeks following the second treatment cycle."
Phase IIb Trials: These trials show "completed"; however, no results have been published. I strongly suspect this study was never actually done, due to Neosil being bought out.
Dosage: the only dosage information I could find was related to PIIb. It defined control groups of:
1. placebo
2. NEOSH101 0.5%
3. NEOSH101 1%
4. NEOSH101 2%
(information from all studies imply, or directly state, a once daily topical application during the administration periods)
----------------------------------------------------------------
Notes:
1. Neosil, Inc. (the company that developed this peptide/use) was bought out for the cost of working capital only. Anyone with any advanced business knowledge will tell you that this is odd. Basically, the company that bought them out bought the rights to this technology and all other proprietary knowledge for $0. That's similar to selling your home, everything in it, and everything on your property (vehicles included) for only the balance of the mortgage. Hardly something that a company that had the "next big thing" would do, UNLESS the owner was in DIRE financial trouble (IRS, maybe?). The new owners discontinued funding for the project.
2. There seems to be a lot of fakes for this peptide floating around right now. Apparently, the raw is difficult to make- thus, the high cost. Trust your source!